On ECHEMI
Home > Drugs > Shenyang Shenlong Pharmaceutical Co., Ltd.
Shenyang Shenlong Pharmaceutical Co., Ltd.
  • Founded in:

    1998-07-19
  • Country:

    China China
  • Address:

    No. 9, Jinhui Street, Hunnan New District, Shenyang
  • Tax NO.:

    912101127209312097
  • Registered Funds:

    5 million yuan
  • Website:

  • Email:

Related Drugs
Tianma Capsules
Gastrodia elata, Notopterygium wilfordii, Angelica dahurica, Eucommia ulmoides (fried with salt), Achyranthes bidentata, Radix Dioscoreae, Aconite root (processed), Angelica sinensis, Rehmannia root, Scrophularia ningpoensis.
Name Description Content CAS NO. Registered Holders
gastrodia tuber

0
RHIZOMA ET RADIX NOTOPTERYGII

0
Angelicae Pubescentis Radix

0
Eucommia ulmoides (fried with salt)

0
Achyranthis bidentatae radix

0
Fenugreek

0
Radix Aconiti Lateralis Preparata Rhizoma Cyperi extract

0
Angelicae Sinensis Radix

0
REHMANNIAE RADIX PRAEPARATA

0
Scrophulariae Radix

0
Compound Danshen Tablets
Danshen, Panax notoginseng, Borneol
Name Description Content CAS NO. Registered Holders
Salvia Root P.E Tanshinone IIA 20%

It can dilate coronary arteries, increase coronary blood flow, and improve myocardial hypoxia; it can improve acute cardiovascular and cerebrovascular symptoms and ischemic changes in the electrocardiogram; it can inhibit platelet aggregation, inhibit platelet release reactions, reduce blood viscosity, and reduce blood lipids.

More

It can dilate coronary arteries, increase coronary blood flow, and improve myocardial hypoxia; it can improve acute cardiovascular and cerebrovascular symptoms and ischemic changes in the electrocardiogram; it can inhibit platelet aggregation, inhibit platelet release reactions, reduce blood viscosity, and reduce blood lipids.

0
NOTOGINSENG RADIX ET RHIZOMA

It can dilate coronary arteries, increase coronary blood flow, and improve myocardial hypoxia; it can improve acute cardiovascular and cerebrovascular symptoms and ischemic changes in the electrocardiogram; it can inhibit platelet aggregation, inhibit platelet release reactions, reduce blood viscosity, and reduce blood lipids.

More

It can dilate coronary arteries, increase coronary blood flow, and improve myocardial hypoxia; it can improve acute cardiovascular and cerebrovascular symptoms and ischemic changes in the electrocardiogram; it can inhibit platelet aggregation, inhibit platelet release reactions, reduce blood viscosity, and reduce blood lipids.

0
Borneol

It can dilate coronary arteries, increase coronary blood flow, and improve myocardial hypoxia; it can improve acute cardiovascular and cerebrovascular symptoms and ischemic changes in the electrocardiogram; it can inhibit platelet aggregation, inhibit platelet release reactions, reduce blood viscosity, and reduce blood lipids.

More

It can dilate coronary arteries, increase coronary blood flow, and improve myocardial hypoxia; it can improve acute cardiovascular and cerebrovascular symptoms and ischemic changes in the electrocardiogram; it can inhibit platelet aggregation, inhibit platelet release reactions, reduce blood viscosity, and reduce blood lipids.

507-70-0 1
Xiaoshuantongluo tablets
Borneol, Chuanxiong, Danshen, Cassia twig, Sophora japonica, Astragalus, Aucklandia, Panax notoginseng, Hawthorn, Curcuma, Alisma orientalis
Name Description Content CAS NO. Registered Holders
Borneol

Dilate cerebral arteries, reduce cerebral circulation resistance and fragility, maintain normal permeability, and improve blood rheology

More

Dilate cerebral arteries, reduce cerebral circulation resistance and fragility, maintain normal permeability, and improve blood rheology

507-70-0 1
Riligustilide

Dilate cerebral arteries, reduce cerebral circulation resistance and fragility, maintain normal permeability, and improve blood rheology

More

Dilate cerebral arteries, reduce cerebral circulation resistance and fragility, maintain normal permeability, and improve blood rheology

89354-45-0 0
Salvia Root P.E Tanshinone IIA 20%

Protect ischemic brain tissue, reduce whole blood and plasma viscosity, and improve blood rheology

More

Protect ischemic brain tissue, reduce whole blood and plasma viscosity, and improve blood rheology

0
Cmnamomi Mmulus

Dilate cerebral arteries, reduce cerebral circulation resistance and fragility, and maintain normal permeability

More

Dilate cerebral arteries, reduce cerebral circulation resistance and fragility, and maintain normal permeability

0
FLOS SOPHORAE

Reduce whole blood and plasma viscosity and improve blood rheology

More

Reduce whole blood and plasma viscosity and improve blood rheology

0
Astragali Radix

Enhance the deformability of red blood cells and improve blood rheology

More

Enhance the deformability of red blood cells and improve blood rheology

0
Aucklandiae Radix

Improve cardiovascular circulation

More

Improve cardiovascular circulation

0
NOTOGINSENG RADIX ET RHIZOMA

Reduce platelet aggregation, reduce fibrinogen, and improve blood rheology

More

Reduce platelet aggregation, reduce fibrinogen, and improve blood rheology

0
Hawthorn

Reduce whole blood and plasma viscosity and improve blood rheology

More

Reduce whole blood and plasma viscosity and improve blood rheology

0
CURCUMAE RADIX

Protect ischemic brain tissue and improve blood rheology

More

Protect ischemic brain tissue and improve blood rheology

0
ALISMATIS RHIZOMA

Reduce whole blood and plasma viscosity and improve blood rheology

More

Reduce whole blood and plasma viscosity and improve blood rheology

0
Ribavirin eye drops
The main ingredient of this product is ribavirin
Name Description Content CAS NO. Registered Holders
Ribavirin

Antiviral drug. It has the effect of inhibiting the growth of many viruses such as respiratory syncytial virus, influenza virus, hepatitis A virus, adenovirus, etc. in vitro, and its mechanism is not fully understood. This product does not change the adsorption, invasion and uncoating of viruses, nor does it induce the production of interferon. After entering the virus-infected cells, the drug is rapidly phosphorylated, and its product acts as a competitive inhibitor of viral synthase, inhibiting inosine monophosphate dehydrogenase, influenza virus RNA polymerase and mRNA guanosine transferase, thereby causing a decrease in intracellular guanosine triphosphate, impairing viral RNA and protein synthesis, and inhibiting viral replication and transmission. It may also have an immune effect and neutralizing antibody effect on respiratory syncytial virus.

More

Antiviral drug. It has the effect of inhibiting the growth of many viruses such as respiratory syncytial virus, influenza virus, hepatitis A virus, adenovirus, etc. in vitro, and its mechanism is not fully understood. This product does not change the adsorption, invasion and uncoating of viruses, nor does it induce the production of interferon. After entering the virus-infected cells, the drug is rapidly phosphorylated, and its product acts as a competitive inhibitor of viral synthase, inhibiting inosine monophosphate dehydrogenase, influenza virus RNA polymerase and mRNA guanosine transferase, thereby causing a decrease in intracellular guanosine triphosphate, impairing viral RNA and protein synthesis, and inhibiting viral replication and transmission. It may also have an immune effect and neutralizing antibody effect on respiratory syncytial virus.

36791-04-5 33
Racemic Anisodamine Hydrochloride Injection
The main ingredient of this product is: racemic anisodamine hydrochloride. Its chemical name is: (±)-6β-hydroxy-1αH, 5αH-tropane-3α-ol tropate hydrochloride.
Name Description Content CAS NO. Registered Holders
Anisodamine

It has a peripheral anti-M cholinergic receptor effect, can relieve smooth muscle spasm caused by acetylcholine, can also relieve microvascular spasm, improve microcirculation, relax gastrointestinal smooth muscle and inhibit its peristalsis; its effect is slightly weaker than atropine, its effect of inhibiting gastrointestinal gland secretion is 1/10 of atropine, and its effect of inhibiting saliva secretion and dilating the pupil is weaker, which is 1/20-1/10 of atropine; because it is not easy to pass through the blood-cerebrospinal fluid barrier, its central effect is also weaker than atropine.

More

It has a peripheral anti-M cholinergic receptor effect, can relieve smooth muscle spasm caused by acetylcholine, can also relieve microvascular spasm, improve microcirculation, relax gastrointestinal smooth muscle and inhibit its peristalsis; its effect is slightly weaker than atropine, its effect of inhibiting gastrointestinal gland secretion is 1/10 of atropine, and its effect of inhibiting saliva secretion and dilating the pupil is weaker, which is 1/20-1/10 of atropine; because it is not easy to pass through the blood-cerebrospinal fluid barrier, its central effect is also weaker than atropine.

17659-49-3 6
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.